A Stock Recent News

A LATEST HEADLINES

A Stock News Image - businesswire.com

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that President and CEO Padraig McDonnell will participate in a fireside chat at this year's Bank of America Global Healthcare Conference in London. The fireside chat will be at 9:50-10:30 a.m. British Summer Time (BST) on Sept. 25 in London. A live audio webcast and replay of the presentation will be available on the Agilent Investor Relations website. About Agilent Technologies Agilent Technologies Inc. (.

businesswire.com 2025 Sep 11
A Stock News Image - seekingalpha.com

Agilent Technologies, Inc. (NYSE:A ) Wells Fargo 20th Annual Healthcare Conference 2025 September 3, 2025 11:00 AM EDT Company Participants Padraig McDonnell - CEO, President & Director Rodney Gonsalves - Interim CFO, Principal Accounting Officer, VP & Corporate Controller Conference Call Participants Brandon Couillard - Wells Fargo Securities, LLC, Research Division Presentation Brandon Couillard MD & Equity Analyst All right. Good morning.

seekingalpha.com 2025 Sep 03
A Stock News Image - zacks.com

Investors interested in stocks from the Medical - Products sector have probably already heard of GE HealthCare Technologies (GEHC) and Agilent Technologies (A). But which of these two stocks is more attractive to value investors?

zacks.com 2025 Sep 03
A Stock News Image - businesswire.com

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that its MMR IHC Panel pharmDx (Dako Omnis) has received class C companion diagnostic (CDx) certification under EU in vitro diagnostic regulation (IVDR)1 as a CDx test for colorectal cancer. MMR IHC Panel pharmDx (Dako Omnis) is indicated as an aid to identify mismatch repair (MMR) deficient CRC patients eligible for treatment with OPDIVO® (nivolumab) in combination with YERVOY® (ipilimumab). MMR IHC Panel.

businesswire.com 2025 Sep 02
A Stock News Image - zacks.com

Evaluate Agilent's (A) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.

zacks.com 2025 Sep 01
A Stock News Image - zacks.com

A posts fiscal Q3 earnings and revenue beats, with double-digit sales growth and upbeat guidance lifting shares.

zacks.com 2025 Aug 28
A Stock News Image - zacks.com

Besides Wall Street's top-and-bottom-line estimates for Agilent (A), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended July 2025.

zacks.com 2025 Aug 22
A Stock News Image - businesswire.com

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that President and CEO Padraig McDonnell will participate in a fireside chat at this year's Wells Fargo Healthcare Conference. The fireside chat will be at 11-11:35 a.m. Eastern on Wednesday, Sept. 3, in Everett, Massachusetts, outside of Boston. A live audio webcast and replay of the presentation will be available on the Agilent Investor Relations website. About Agilent Technologies Agilent Technologies I.

businesswire.com 2025 Aug 21
A Stock News Image - businesswire.com

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that its MMR IHC Panel pharmDx (Dako Omnis) has received FDA approval as a companion diagnostic (CDx) test for colorectal cancer. This test aids in identifying mismatch repair deficient (dMMR) colorectal cancer (CRC) patients who are eligible for treatment with Bristol Myers Squibb's Opdivo® (nivolumab) alone or Opdivo (nivolumab) in combination with Yervoy® (ipilimumab). The MMR IHC Panel pharmDx (Dako Om.

businesswire.com 2025 Aug 20
A Stock News Image - zacks.com

Investors looking for stocks in the Medical - Products sector might want to consider either GE HealthCare Technologies (GEHC) or Agilent Technologies (A). But which of these two stocks offers value investors a better bang for their buck right now?

zacks.com 2025 Aug 18
10 of 42